Advisory Committee on Immunization Practices (ACIP)
Total Page:16
File Type:pdf, Size:1020Kb
DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR DISEASE CONTROL AND PREVENTION Advisory Committee on Immunization Practices (ACIP) Summary Report February 20-21, 2013 Atlanta, Georgia This document has been archived for historical purposes. (3/1/2013) https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-feb13.pdf Advisory Committee on Immunization Practices (ACIP) Summary Report February 20-21, 2013 Table of Contents Page Agenda 4-5 Acronyms 6-7 Wednesday: February 20, 2013 Welcome and Introductions 8-11 Agency Updates CDC Center for Medicare and Medicaid Services (CMS) Department of Defense (DoD) Department of Veteran’s Affairs (DVA) Food and Drug Administration (FDA) 11-14 Heath Resources and Services Administration (HRSA) Indian Health Services (I HS) National Institutes of Health (NIH) National Vaccine Advisory Committee (NVAC) National Vaccine Program Office (NVPO) Pneumococcal Vaccines Introduction Impact of PCV13 Use in Children 14-27 PCV13 for Children 6 through 18 Years Old with Immunocompromising Conditions: GRADE PCV13 Recommendations for Children 6 through 18 Years Old with Immunocompromising Conditions Vaccines for Children Program Resolution Haemophilus Influenzae b (Hib)l Vaccine Introduction Updates Hib Vaccine Recommendations 28-47 Vaccines for Children: Hib-MenCY Japanese Encephalitis Introduction 48-54 Japanese Encephalitis Vaccine for US Travelers Pertussis Vaccines Introduction 55-72 Update on Immunization Safety Monitoring: Tdap Administered to Pregnant Women Pertussis in the United States and Tdap Revaccination Smallpox Vaccine Work Group 73-74 Vaccine Supply 74 General Recommendations Introduction Timing and Spacing of Immunobiologics 74-88 Contraindications and Precautions Special Situations Measles and Rubella Initiative 88-93 2 This document has been archived for historical purposes. (3/1/2013) https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-feb13.pdf Advisory Committee on Immunization Practices (ACIP) Summary Report February 20-21, 2013 Global Polio Eradication Initiative 93-97 Public Comments Day 1 98 Thursday: February 21, 2013 Distinguished Service Medal Presentation 98 Farewell to Sara Rosenbaum 99-100 IOM Immunization Schedule Report 100-105 Adult Immunization Introduction Update on Adult Immunization Coverage 106-120 Provider Survey Results on Adult Immunization Consumer Awareness Regarding Adult Immunization Influenza Introduction Epidemiology and Surveillance Update Vaccine Supply 120-144 Vaccine Effectiveness FluBlok® Upcoming Topics Proposed 2013-2014 Recommendations Public Comment Day 2 144 Certification 145 Membership Roster 146-154 3 This document has been archived for historical purposes. (3/1/2013) https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-feb13.pdf FINAL - February 20, 2013 MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) Centers for Disease Control and Prevention 1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Kent "Oz" Nelson Auditorium Atlanta, Georgia 30333 February 20-21, 2013 AGENDA ITEM PURPOSE PRESIDER/PRESENTER(s) Wednesday, February 20, 2013 8:00 Welcome & Introductions Dr. Jonathan Temte (ACIP Chair) Dr. Larry Pickering (Executive Secretary, ACIP) 8:30 Agency Updates · CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NVPO, NIH 8:45 Pneumococcal Vaccines · Introduction Dr. Nancy Bennett (ACIP, WG Chair) · Impact of PCV13 use in children Dr. Matthew Moore (CDC/NCIRD/DBD) Information & · PCV13 for children 6 through 18 years old with Discussion Ms. Tamara Pilishvili (CDC/NCIRD/DBD) immunocompromising conditions: GRADE · PCV13 recommendations for children 6 through 18 years old Vote Ms. Tamara Pilishvili (CDC/NCIRD/DBD) with immunocompromising conditions · Vaccines for Children VFC Vote Dr. Jeanne Santoli (CDC/NCIRD) 10:00 Break 10:30 Haemophilus influenzae b (Hib) Vaccine · Introduction Information, Dr. Lorry Rubin (ACIP, WG Chair) · Updated Hib Vaccine Recommendations Discussion & Dr. Elizabeth Briere (CDC/NCIRD) Vote · Vaccines for Children: Hib-MenCY VFC Vote Dr. Jeanne Santoli (CDC/NCIRD) 11:30 Japanese Encephalitis · Introduction Information & Dr. Joseph Bocchini (ACIP, WG Chair) · Japanese encephalitis vaccine for U.S. travelers Discussion Dr. Marc Fischer (CDC/NCEZID) 12:15 Lunch 1:30 Pertussis Vaccines · Introduction Dr. Mark Sawyer (ACIP, WG Chair) · Update on immunization safety monitoring: Tdap Dr. Frank Destefano (CDC/NCEZID) Information & administered to pregnant women Discussion · Pertussis in the United States and Tdap revaccination Dr. Thomas Clark (CDC/NCIRD) 3:15 Break 3:30 Smallpox Vaccine Work Group Information Dr. Lee Harrison (ACIP, WG Chair) 3:35 Vaccine Supply Information Dr. Jeanne Santoli (CDC/NCIRD) 3:45 General Recommendations · Introduction Dr. Jeff Duchin (ACIP, WG Chair) · Timing and spacing of immunobiologics Information & · Contraindications and precautions Discussion Dr. Andrew Kroger (CDC/NCIRD) · Special situations 5:00 Measles and Rubella Initiative Information Dr. Lisa Cairns (CDC/CGH/GID) 5:30 Global Polio Eradication Initiative Information Dr. Robert Linkins (CDC/CGH/GID) 6:00 Public Comment 6:15 Adjourn This document has been archived for historical purposes. (3/1/2013) page 1 of 2 https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-feb13.pdf Final - February 20, 2013 Thursday, February 21, 2013 8:00 Unfinished Business Dr. Jonathan Temte (Chair, ACIP) 8:15 IOM Immunization Schedule Report Dr. Ada Hinshaw* (Uniformed Services University Information & of the Health Sciences, Bethesda, MD) Discussion 9:00 Adult Immunization · Introduction Dr. Tamara Coyne-Beasley (ACIP, WG Chair) Dr. Carolyn Bridges (CDC/NCIRD) · Updated adult immunization coverage Dr. Walter Williams (CDC/NCIRD) Information & · Provider survey results on adult immunization Dr. Laura Hurley (University of Colorado) Discussion · Consumer awareness regarding adult immunization Dr. Kris Sheedy (CDC/NCIRD) · Discussion Dr. Tamara Coyne-Beasley (ACIP, WG Chair) Dr. Carolyn Bridges (CDC/NCIRD) 10:15 Break 10:45 Influenza · Introduction Dr.Wendy Keitel (ACIP, WG Chair) · Epidemiology and surveillance update Dr. Lyn Finelli (CDC/NCIRD) · Vaccine Supply Information Dr. Jeanne Santoli (CDC/NCIRD) · Vaccine effectiveness & Dr. Mark Thompson (CDC/NCIRD) · FluBlok Discussion Dr. Lisa Dunkle (Protein Sciences) · Upcoming topics Dr. Lisa Grohskopf (CDC/NCIRD) · Proposed 2013-2014 recommendations Vote Dr. Lisa Grohskopf (CDC/NCIRD) 1:15 Public Comment 1:30 Adjourn * Chair, Committee on the Assessment of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Institute of Medicine Acronyms GRADE Grading of Recommendations Assessment, Development and Evaluation NCEZID National Center for Emerging and Zoonotic Infectious Diseases NCIRD National Center for Immunization and Respiratory Diseases TBD To be determined Tdap Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine WG Work Group This document has been archived for historical purposes. (3/1/2013) page 2 of 2 https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-feb13.pdf Advisory Committee on Immunization Practices (ACIP) Summary Report February 20-21, 2013 Acronyms AAFP American Academy of Family Physicians AAP American Academy of Pediatrics ABCs Active Bacterial Core Surveillance ACA Affordable Care Act ACHA American College Health Association ACOG American College of Obstetricians and Gynecologists ACP American College of Physicians ACIP Advisory Committee on Immunization Practices AE Adverse Events AFP American Family Physicians AFP Acute Flaccid Paralysis AHIP America’s Health Insurance Plans AI/AN American Indians/Alaska Natives AIM Association of Immunization Managers AMA American Medical Association ANA American Nurses Association Anti-FIM Anti-Fimbrial Agglutinogens aP Acellular Pertussis APERT Adult Pertussis Trial APhA American Pharmacists Association BARDA Biomedical Advanced Research and Development Authority BEVS Baculovirus Expression Vector System BLA Biologics License Application BMBL Biosafety in Microbiological and Biomedical Laboratories CAPITA Community Acquired Pneumonia Immunization Trial in Adults CDC Centers for Disease Control and Prevention CISA Clinical Immunization Safety Assessment CMS Centers for Medicare and Medicaid Services COPD Chronic Obstructive Pulmonary Disease CRS Congenital Rubella Syndrome DSMB Data Safety Monitoring Board DTaP Diphtheria, Tetanus, and Pertussis DVA Department of Veterans Affairs EHR Electronic Health Record EOC Emergency Operations Center EMA European Medicines Agency EMR Electronic Medical Record FDA Food and Drug Administration FM Family Medicine Physicians FMAP Federal Medical Assistance Percentage GBS Guillain–Barré Syndrome GIM General Internists GMCs Geometric Mean Concentrations GMFRs Geometric Mean Fold Rises GMTs Geometric Mean Titers GPEI Global Polio Eradication Initiative GRADE Grading of Recommendation Assessment, Development and Evaluation GSK GlaxoSmithKline GVAP Global Vaccine Action Plan HA Hemagglutinin HP2020 Healthy People 2020 HHS (Department of) Health and Human Services Hib Haemophilus influenzae B HICPAC Hospital Infection Control Practices Advisory Committee hMPV Human metapneumovirus hPIV Human Parainfluenza Virus HPV Human Papillomavirus HRSA Health Resources and Services Administration HSCT Hematopoietic Stem Cell Transplant IDSA Infectious Disease Society of America IgG Immunoglobulin G ILI Influenza-Like Illness ILINet Influenza-Like